miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine

SIMPLE SUMMARY: Non-Hodgkin’s lymphoma (NHL) is a very heterogenous class of hematological cancers, with variable patient outcomes. Therefore, there is an urgent need to develop new and more effective therapeutic approaches. MiRNAs and lncRNAs have emerged as the central gene expression regulators,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Mara, Marques, Herlander, Teixeira, Ana Luísa, Medeiros, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699447/
https://www.ncbi.nlm.nih.gov/pubmed/34944942
http://dx.doi.org/10.3390/cancers13246324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699447/
https://www.ncbi.nlm.nih.gov/pubmed/34944942
http://dx.doi.org/10.3390/cancers13246324

Ejemplares similares